These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36588502)

  • 21. Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer's disease: a 24-month follow-up study.
    Conde-Sala JL; Turró-Garriga O; Piñán-Hernández S; Portellano-Ortiz C; Viñas-Diez V; Gascón-Bayarri J; Reñé-Ramírez R
    Int J Geriatr Psychiatry; 2016 Feb; 31(2):109-19. PubMed ID: 25963296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apathy in Alzheimer's disease: Contribution to a clinical view on progression of dementia.
    Stella F; de Andrade LP; Vital TM; Coelho FGM; Nascimento CMC; Hernández SSS
    Dement Neuropsychol; 2010; 4(3):188-193. PubMed ID: 29213685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a non-focal plasticity protocol on apathy in moderate Alzheimer's disease: a randomized, double-blind, sham-controlled trial.
    Suemoto CK; Apolinario D; Nakamura-Palacios EM; Lopes L; Leite RE; Sales MC; Nitrini R; Brucki SM; Morillo LS; Magaldi RM; Fregni F
    Brain Stimul; 2014; 7(2):308-13. PubMed ID: 24262299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
    Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
    Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular dementia versus dementia of Alzheimer's type: do they have differential effects on caregivers' burden?
    Vetter PH; Krauss S; Steiner O; Kropp P; Möller WD; Moises HW; Köller O
    J Gerontol B Psychol Sci Soc Sci; 1999 Mar; 54(2):S93-8. PubMed ID: 10097779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer's disease dementia.
    Banning LCP; Ramakers IHGB; Rosenberg PB; Lyketsos CG; Leoutsakos JS;
    Int J Geriatr Psychiatry; 2021 Jan; 36(1):224-234. PubMed ID: 32869375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
    Vik-Mo AO; Giil LM; Ballard C; Aarsland D
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of caregiver demographic variables with neuropsychiatric symptoms in Alzheimer's disease patients for distress on the Neuropsychiatric Inventory (NPI).
    Godinho C; Camozzato A; Kochhann R; Chaves MLF
    Dement Neuropsychol; 2008; 2(3):211-216. PubMed ID: 29213573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type.
    Chow TW; Binns MA; Cummings JL; Lam I; Black SE; Miller BL; Freedman M; Stuss DT; van Reekum R
    Arch Neurol; 2009 Jul; 66(7):888-93. PubMed ID: 19597092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of neuropsychiatric syndromes with global clinical deterioration in Alzheimer's disease patients.
    Stella F; Laks J; Govone JS; de Medeiros K; Forlenza OV
    Int Psychogeriatr; 2016 May; 28(5):779-86. PubMed ID: 26673910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease.
    Wimo A; Winblad B; Stöffler A; Wirth Y; Möbius HJ
    Pharmacoeconomics; 2003; 21(5):327-40. PubMed ID: 12627986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological interventions for apathy in Alzheimer's disease.
    Ruthirakuhan MT; Herrmann N; Abraham EH; Chan S; Lanctôt KL
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012197. PubMed ID: 29727467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.
    Rosenberg PB; Lanctôt KL; Drye LT; Herrmann N; Scherer RW; Bachman DL; Mintzer JE; ADMET Investigators
    J Clin Psychiatry; 2013 Aug; 74(8):810-6. PubMed ID: 24021498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
    Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
    Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers.
    Pang FC; Chow TW; Cummings JL; Leung VP; Chiu HF; Lam LC; Chen QL; Tai CT; Chen LW; Wang SJ; Fuh JL
    Int J Geriatr Psychiatry; 2002 Jan; 17(1):29-34. PubMed ID: 11802227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
    Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
    J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status.
    Niermeyer M; Gaudet C; Malloy P; Piryatinsky I; Salloway S; Klinge P; Lee A
    J Int Neuropsychol Soc; 2020 Oct; 26(9):883-893. PubMed ID: 32430087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs and resource use of community-dwelling patients with Alzheimer's disease in Japan: 18-month results from the GERAS-J study.
    Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Matsumura T; Meguro K; Yamada M; Mimura M; Arai H; Treuer T
    Curr Med Res Opin; 2021 Aug; 37(8):1331-1339. PubMed ID: 33904362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apathy and
    Vellone D; Ghahremani M; Goodarzi Z; Forkert ND; Smith EE; Ismail Z
    Alzheimers Dement (N Y); 2022; 8(1):e12370. PubMed ID: 36544988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.
    Gustavsson A; Cattelin F; Jönsson L
    Alzheimers Dement; 2011 Jul; 7(4):466-73. PubMed ID: 21784355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.